Free Trial

Louisiana State Employees Retirement System Invests $4.87 Million in Avantor, Inc. (NYSE:AVTR)

Avantor logo with Medical background

Louisiana State Employees Retirement System bought a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 188,400 shares of the company's stock, valued at approximately $4,874,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Versant Capital Management Inc lifted its holdings in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after buying an additional 1,102 shares during the period. Blue Trust Inc. raised its position in shares of Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock worth $31,000 after acquiring an additional 1,391 shares in the last quarter. UMB Bank n.a. bought a new position in shares of Avantor in the 3rd quarter worth about $49,000. GAMMA Investing LLC raised its position in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock worth $70,000 after acquiring an additional 1,285 shares in the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in shares of Avantor in the 1st quarter worth about $93,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business's stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares of the company's stock, valued at approximately $740,372.64. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AVTR. Wells Fargo & Company began coverage on Avantor in a research report on Tuesday, August 27th. They issued an "overweight" rating and a $30.00 price objective for the company. Robert W. Baird lifted their price objective on Avantor from $26.00 to $27.00 and gave the stock an "outperform" rating in a research report on Monday, July 29th. Royal Bank of Canada reissued an "outperform" rating and issued a $34.00 price objective on shares of Avantor in a research report on Thursday, September 26th. TD Cowen lifted their price objective on Avantor from $28.00 to $31.00 and gave the stock a "buy" rating in a research report on Monday, July 29th. Finally, UBS Group decreased their target price on Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a research report on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.79.

Read Our Latest Research Report on Avantor

Avantor Stock Down 3.6 %

AVTR traded down $0.84 during midday trading on Friday, reaching $22.43. 10,187,187 shares of the company were exchanged, compared to its average volume of 6,449,887. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. The company's fifty day moving average price is $25.49 and its 200 day moving average price is $24.26. The company has a market cap of $15.24 billion, a price-to-earnings ratio of 57.51, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33. Avantor, Inc. has a one year low of $16.63 and a one year high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings data on Friday, October 25th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.01. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.72 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. As a group, analysts expect that Avantor, Inc. will post 1.01 EPS for the current year.

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Should you invest $1,000 in Avantor right now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines